Draper Asset Management LLC Has $1.53 Million Position in Intuitive Surgical, Inc. $ISRG

Draper Asset Management LLC boosted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 41.3% during the 2nd quarter, Holdings Channel reports. The institutional investor owned 2,865 shares of the medical equipment provider’s stock after buying an additional 838 shares during the quarter. Intuitive Surgical comprises approximately 1.0% of Draper Asset Management LLC’s investment portfolio, making the stock its 14th largest holding. Draper Asset Management LLC’s holdings in Intuitive Surgical were worth $1,529,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Carnegie Investment Counsel lifted its holdings in Intuitive Surgical by 13.3% during the 2nd quarter. Carnegie Investment Counsel now owns 750 shares of the medical equipment provider’s stock worth $408,000 after buying an additional 88 shares during the period. Avion Wealth raised its position in shares of Intuitive Surgical by 2.3% in the 2nd quarter. Avion Wealth now owns 984 shares of the medical equipment provider’s stock worth $534,000 after acquiring an additional 22 shares in the last quarter. FSM Wealth Advisors LLC raised its position in shares of Intuitive Surgical by 65.4% in the 2nd quarter. FSM Wealth Advisors LLC now owns 903 shares of the medical equipment provider’s stock worth $483,000 after acquiring an additional 357 shares in the last quarter. KPP Advisory Services LLC raised its position in shares of Intuitive Surgical by 48.1% in the 2nd quarter. KPP Advisory Services LLC now owns 2,057 shares of the medical equipment provider’s stock worth $1,118,000 after acquiring an additional 668 shares in the last quarter. Finally, First Citizens Bank & Trust Co. raised its position in shares of Intuitive Surgical by 34.3% in the 2nd quarter. First Citizens Bank & Trust Co. now owns 20,476 shares of the medical equipment provider’s stock worth $11,127,000 after acquiring an additional 5,227 shares in the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, insider Gary S. Guthart sold 29,360 shares of Intuitive Surgical stock in a transaction dated Friday, August 29th. The stock was sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the completion of the transaction, the insider owned 19,827 shares in the company, valued at approximately $9,368,059.23. The trade was a 59.69% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Amy L. Ladd sold 336 shares of Intuitive Surgical stock in a transaction dated Wednesday, September 3rd. The shares were sold at an average price of $470.11, for a total value of $157,956.96. Following the transaction, the director owned 1,074 shares of the company’s stock, valued at $504,898.14. This trade represents a 23.83% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 40,724 shares of company stock valued at $19,500,332 in the last quarter. Company insiders own 0.70% of the company’s stock.

Analysts Set New Price Targets

Several research firms have recently weighed in on ISRG. Weiss Ratings reissued a “hold (c+)” rating on shares of Intuitive Surgical in a research report on Wednesday, October 8th. Wells Fargo & Company lifted their price objective on Intuitive Surgical from $599.00 to $600.00 and gave the stock an “overweight” rating in a research report on Wednesday. Robert W. Baird set a $655.00 price objective on Intuitive Surgical in a research report on Wednesday. Sanford C. Bernstein reissued an “outperform” rating and issued a $685.00 price objective on shares of Intuitive Surgical in a research report on Tuesday. Finally, Truist Financial set a $620.00 price objective on Intuitive Surgical and gave the stock a “buy” rating in a research report on Wednesday. Eighteen research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus target price of $604.50.

Intuitive Surgical Stock Performance

ISRG stock opened at $551.30 on Friday. The company has a market capitalization of $197.63 billion, a P/E ratio of 72.92, a price-to-earnings-growth ratio of 5.53 and a beta of 1.61. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $616.00. The business has a 50-day simple moving average of $456.77 and a two-hundred day simple moving average of $496.40.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.99 by $0.41. The business had revenue of $2.51 billion during the quarter, compared to the consensus estimate of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The company’s quarterly revenue was up 22.9% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.84 EPS. As a group, sell-side analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.